Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid

Biomarkers in amniotic fluid (AF) include both non-modified and phosphorylated proteins and can be used in the diagnosis of pregnancy-associated pathologic conditions. In this work, an integrated LC–MS method for selective, sensitive and reproducible analysis of phosphorylation in proteins has been applied to AF. Online digestion of (phospho) proteins was coupled with the selective enrichment on a TiO2 trap, and separated by RPLC–MSn of both normal and phosphorylated produced peptides. First, an AF-pooled sample was analyzed and a general map of contained proteins and biomarkers was derived in a single run. Then, individual AF samples were analyzed with a downscaled platform with improved sensitivity. On purpose, a trypsin-based CIM® minidisk was used for online digestion of AF. The obtained protein profile was highly consistent with the one obtained with traditional off-line digestions. Moreover, the use of a specific phospho-enrichment tool followed by LTQ-Orbitrap, enhanced the confidence in the determination of protein phosphorylation state and phosphorylation sites. The phosphorylation sites of IGFBP-1 and osteopontin present in the AF of two individual samples were monitored with a total of 24 and 17 phosphopeptides, respectively, encoding for 12 putative novel phosphorylation sites in addition to known sites.

[1]  Martin R Larsen,et al.  The use of titanium dioxide micro-columns to selectively isolate phosphopeptides from proteolytic digests. , 2009, Methods in molecular biology.

[2]  Y. Lim,et al.  Phosphoproteomics, oncogenic signaling and cancer research , 2008, Proteomics.

[3]  G. Tsangaris,et al.  The normal human amniotic fluid supernatant proteome. , 2006, In vivo.

[4]  E. Diamandis,et al.  Proteomics Analysis of Human Amniotic Fluid *S , 2007, Molecular & Cellular Proteomics.

[5]  S. Mohammed,et al.  Phosphopeptide fragmentation and analysis by mass spectrometry. , 2009, Journal of mass spectrometry : JMS.

[6]  J. Khosravi,et al.  Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity. , 2009, Endocrinology.

[7]  D. T. Wong,et al.  Human body fluid proteome analysis , 2006, Proteomics.

[8]  L. Visai,et al.  Identification of the amniotic fluid insulin‐like growth factor binding protein‐1 phosphorylation sites and propensity to proteolysis of the isoforms , 2009, The FEBS journal.

[9]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[10]  E. Jauniaux,et al.  Insulin-like growth factor binding protein concentration and post-translational modification in embryological fluid. , 1997, Molecular human reproduction.

[11]  Albert Sickmann,et al.  State‐of‐the‐art in phosphoproteomics , 2005, Proteomics.

[12]  Rovshan G Sadygov,et al.  Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book , 2004, Nature Methods.

[13]  B. Dastugue,et al.  Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach , 2003, Proteomics.

[14]  C. C. Pillai,et al.  Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.

[15]  N. C. Tedford,et al.  Quantitative analysis of cell signaling and drug action via mass spectrometry‐based systems level phosphoproteomics , 2009, Proteomics.

[16]  Tao Liu,et al.  Utilizing human blood plasma for proteomic biomarker discovery. , 2005, Journal of proteome research.

[17]  M. Mann,et al.  Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. , 2008, Journal of proteome research.

[18]  S. Oh,et al.  Proteome analysis of human amnion and amniotic fluid by two‐dimensional electrophoresis and matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry , 2006, Proteomics.

[19]  Robert A Harris,et al.  Quantitative mitochondrial phosphoproteomics using iTRAQ on an LTQ-Orbitrap with high energy collision dissociation. , 2009, Journal of proteome research.

[20]  T. Spencer,et al.  Minireview. Osteopontin: Roles in Implantation and Placentation1 , 2003, Biology of reproduction.

[21]  Forest M White,et al.  Quantitative phosphoproteomics by mass spectrometry: Past, present, and future , 2008, Proteomics.

[22]  Ruedi Aebersold,et al.  PhosphoPep—a database of protein phosphorylation sites in model organisms , 2008, Nature Biotechnology.

[23]  Paul Taylor,et al.  Emerging applications for phospho-proteomics in cancer molecular therapeutics. , 2006, Biochimica et biophysica acta.

[24]  Magnus Palmblad,et al.  Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. , 2004, Journal of proteome research.

[25]  Alexey I Nesvizhskii,et al.  Protein identification by tandem mass spectrometry and sequence database searching. , 2007, Methods in molecular biology.

[26]  M. Mann,et al.  Global and site-specific quantitative phosphoproteomics: principles and applications. , 2009, Annual review of pharmacology and toxicology.

[27]  Junjie Hou,et al.  Phosphoproteome analysis of rat L6 myotubes using reversed-phase C18 prefractionation and titanium dioxide enrichment. , 2010, Journal of proteome research.

[28]  V. Han,et al.  Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. , 2005, The Journal of endocrinology.

[29]  C. Buhimschi,et al.  Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth , 2008, PloS one.

[30]  Juan Pablo Albar,et al.  Advances in the analysis of protein phosphorylation. , 2008, Journal of proteome research.

[31]  M. Galliano,et al.  Mapping the 5–50‐kDa fraction of human amniotic fluid proteins by 2‐DE and ESI‐MS , 2007, Proteomics. Clinical applications.

[32]  J. Solassol,et al.  Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids , 2008, Proteome Science.

[33]  M. Bruening,et al.  Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry. , 2009, Mass spectrometry reviews.

[34]  M. Larsen,et al.  Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry. , 2008, Analytical chemistry.

[35]  C. Buhimschi,et al.  Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammation , 2005, BJOG : an international journal of obstetrics and gynaecology.

[36]  A. Scaloni,et al.  Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. , 2007, Journal of proteome research.

[37]  G. Massolini,et al.  Development of an integrated chromatographic system for on-line digestion and characterization of phosphorylated proteins. , 2008, Journal of chromatography. A.

[38]  Riccardo Bellazzi,et al.  A procedure to decompose high resolution mass spectra , 2007, BMC Bioinformatics.

[39]  J. Deprest,et al.  Proteomic analyses of amniotic fluid: potential applications in health and diseases. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  J. Rossier,et al.  Proteome analysis of human plasma and amniotic fluid by Off‐Gel™ isoelectric focusing followed by nano‐LC‐MS/MS , 2006, Electrophoresis.

[41]  Caterina Temporini,et al.  Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. , 2008, Mass spectrometry reviews (Print).

[42]  Henrik Zetterberg,et al.  Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. , 2005, Journal of proteome research.

[43]  Florian Gnad,et al.  High‐accuracy identification and bioinformatic analysis of in vivo protein phosphorylation sites in yeast , 2009, Proteomics.

[44]  Min-Seok Kwon,et al.  Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen , 2009, Proteomics.

[45]  J. Lapidus,et al.  Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. , 2004, JAMA.

[46]  J. Veuthey,et al.  Trypsin immobilization on an ethylenediamine-based monolithic minidisk for rapid on-line peptide mass fingerprinting studies. , 2009, Journal of chromatography. A.

[47]  Joost W Gouw,et al.  Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. , 2008, Journal of proteome research.

[48]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[49]  M. I. Hassan,et al.  Proteomic analysis of human amniotic fluid from Rh− pregnancy , 2008, Prenatal diagnosis.

[50]  Amanda Doherty-Kirby,et al.  Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. , 2005, Biochemistry.

[51]  D. Denhardt,et al.  Control of osteopontin signaling and function by post‐translational phosphorylation and protein folding , 2007, Journal of cellular biochemistry.

[52]  Rainer Malik,et al.  Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis. , 2008, Analytical chemistry.

[53]  G. Tsangaris,et al.  Proteomics in prenatal diagnosis , 2009, Expert review of proteomics.

[54]  T. Ryan,et al.  Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID‐HCD for global identification and quantitative analysis of phosphopeptides , 2010, Proteomics.

[55]  G. Tsangaris,et al.  Proteomic analysis of amniotic fluid in pregnancies with Down syndrome , 2006, Proteomics.

[56]  Leonardo Pereira,et al.  Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. , 2007, Journal of proteome research.

[57]  John R Yates,et al.  Proteomics by mass spectrometry: approaches, advances, and applications. , 2009, Annual review of biomedical engineering.

[58]  A. Heck,et al.  Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. , 2004, Analytical chemistry.

[59]  Ruedi Aebersold,et al.  Reproducible isolation of distinct, overlapping segments of the phosphoproteome , 2007, Nature Methods.

[60]  Heribert Hirt,et al.  Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks , 2008, Proteomics.

[61]  Lennart Martens,et al.  Computational Methods for Mass Spectrometry Proteomics , 2008 .

[62]  J. Yates,et al.  Mass spectrometry for proteomics. , 2008, Current opinion in chemical biology.

[63]  E. Salih.  Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. , 2005, Mass spectrometry reviews.

[64]  M. Collins,et al.  Analysis of protein phosphorylation on a proteome‐scale , 2007, Proteomics.

[65]  J. Yates,et al.  Optimizing TiO2-based phosphopeptide enrichment for automated multidimensional liquid chromatography coupled to tandem mass spectrometry. , 2007, Analytical chemistry.

[66]  R. Zeng,et al.  Fully automatic separation and identification of phosphopeptides by continuous pH-gradient anion exchange online coupled with reversed-phase liquid chromatography mass spectrometry. , 2009, Journal of proteome research.

[67]  V. Bhandari,et al.  Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis , 2007, PLoS medicine.

[68]  Xuewu Zhang,et al.  Mass spectrometry-based "omics" technologies in cancer diagnostics. , 2007, Mass spectrometry reviews.

[69]  G. Tsangaris,et al.  Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. , 2008, Journal of proteome research.

[70]  M. Larsen,et al.  Analytical strategies for phosphoproteomics , 2009, Expert review of neurotherapeutics.